BRAF and neoplasm: Notably, there was no significant difference in the anticancer effect of selenite between the BRAF wildtype (WT) tumor cells (TPC-1, KTC-1, and KHM-5M) and the BRAFV600E-positive tumor cells (BCPAP and 8505c).